Genoskin Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $61.6K

  • Investors
  • 4

Genoskin General Information

Description

Developer of ex vivo human skin models intended to facilitate the efficacy and toxicity testing of pharmaceutical, cosmetic, and chemical products. The company provides reliable human data before regulatory studies for human therapeutics, vaccines, medical devices, cosmetics, and chemicals and its technology permits stable and long-term ex vivo cultivation of fresh human skin biopsies without loss of tissue integrity, morphology, physiology, and cutaneous barrier function, enabling pharmaceutical and cosmetic product companies to test on real human tissue collected after surgery which is kept alive through an ex vivo culture system to avoid animal experiments.

Contact Information

Website
www.genoskin.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 1, Place Pierre Potier
  • 31100 Toulouse
  • France
+33 09
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1, Place Pierre Potier
  • 31100 Toulouse
  • France
+33 09

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genoskin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 23-Mar-2018 $61.6K Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
2. Grant 28-Jun-2011 Completed Startup
1. Accelerator/Incubator 01-Sep-2009 Completed Startup
To view Genoskin’s complete valuation and funding history, request access »

Genoskin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of ex vivo human skin models intended to facilitate the efficacy and toxicity testing of pharmaceutical, cosme
Biotechnology
Toulouse, France
45 As of 2025

Schlieren, Switzerland
 

Alameda, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genoskin Competitors (21)

One of Genoskin’s 21 competitors is InSphero, a Venture Capital-Backed company based in Schlieren, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Venture Capital-Backed Schlieren, Switzerland
AllCells Private Equity-Backed Alameda, CA
Epithelix Corporation Geneva, Switzerland
Synthecon Formerly Accelerator/Incubator backed Houston, TX
Ncardia Venture Capital-Backed Leiden, Netherlands
You’re viewing 5 of 21 competitors. Get the full list »

Genoskin Patents

  • 40

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

Genoskin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4382909-A1 Multiplex annoted tissue imaging system Inactive 07-Dec-2022
FR-3132146-A1 Ex vivo human model intended for the evaluation of the vaccine potential of a composition Pending 27-Jan-2022
EP-4469797-A1 Ex vivo human model designed to evaluate the vaccine potential of a composition Pending 27-Jan-2022
US-20240410878-A1 Ex vivo human model intended for evaluating the vaccine potential of a composition Pending 27-Jan-2022
FR-3123125-A1 Ex vivo human model intended for the evaluation of the inflammatory potential of the allergic or pseudo-allergic type Pending 20-May-2021 G01N33/5082
To view Genoskin’s complete patent history, request access »

Genoskin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genoskin Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Horizon 2020 SME Instrument Government
InnoVentures Lab Accelerator/Incubator Minority
OSEO Innovation Venture Capital Minority
Nubbo Accelerator/Incubator
To view Genoskin’s complete investors history, request access »

Ready to get started?

Request a free trial

Genoskin FAQs

  • When was Genoskin founded?

    Genoskin was founded in 2009.

  • Where is Genoskin headquartered?

    Genoskin is headquartered in Toulouse, France.

  • What is the size of Genoskin?

    Genoskin has 45 total employees.

  • What industry is Genoskin in?

    Genoskin’s primary industry is Biotechnology.

  • Is Genoskin a private or public company?

    Genoskin is a Private company.

  • What is Genoskin’s current revenue?

    The current revenue for Genoskin is .

  • Who are Genoskin’s investors?

    Horizon 2020 SME Instrument, InnoVentures Lab, OSEO Innovation, and Nubbo have invested in Genoskin.

  • Who are Genoskin’s competitors?

    InSphero, AllCells, Epithelix, Synthecon, and Ncardia are some of the 21 competitors of Genoskin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »